Himuka AM Pharma Corp.
PrivateLast Round
Series B
Jan 14, 2022
Total Funding Raised
$10.67M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Himuka AM Pharma Corp. is a clinical-stage biopharmaceutical company that develops drug candidates based on derivatives of the bioactive peptide adrenomedullin to address unmet medical needs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Himuka AM Pharma Corp. Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Himuka AM Pharma Corp. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 14, 2022 | ||||
| Series A | Jun 19, 2018 |
Himuka AM Pharma Corp. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Keio Innovation Initiative | Series A |
| Nanto Bank | Series B |
| 日本ベンチャーキャピタル株式会社 | Series A |
| Miyazaki Taiyo Capital | Series B, Series A |
| Venture Labo Investment | Series B |
| Axil Capital Partners | Series A |
| QB Capital | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 24, 2026
Monthly visitors grew 40% MoM.
Himuka AM Pharma Corp. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Himuka AM Pharma Corp.'s valuation, stock price, and market status.